- Lobbying
- Lobbying by Cephalon, Inc.
Lobbying Relationship
Bills mentioned
S.369: Preserve Access to Affordable Generics Act
Sponsor: Herb Kohl (D-Wis.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
David Urban | Chief of Staff, Senator Arlen Specter, 1997-2002 |
James Smith | Chief of Staff, Rep. Peter Deutsch, 1993-1997 |
Carlyle Thorsen | General Counsel, Rep. Tom DeLay, 2004-2005 Admin. Asst., Rep. Tom DeLay, 2002-2004 Deputy Assistant Attorney General, DOJ, 2001-2002 Counsel, House Judiciary Committee, 1999-2001 Legislative Counsel, Rep Bill McCollum, 1999 Legislative Counsel, Rep. Frank LoBiondo, 1996-1999 General Counsel/AA, Rep. Tom DeLay Deputy Asst. Attorney General, DOJ Legislative Counsel, Rep McCollum & LoBiondo |
Shawn Smeallie | Special Asst. Pres. Bush for Legislative Affairs, 1990-1993 Special Asst. to Dir. for Leg. Affairs at OMB, 1989-1990 Special Asst to Pres Bush for Legislative Affairs Special Asst to Director for Leg Affairs at OMB |
Trista Roehl | LA, Rep. John Shadegg; LA, Rep. Chris Cox; LA, Rep. Pat Toomey |
Chris Israel | US Coord for Int'l IP Enforcement Dep Chief of Staff, Dept of Commerce Dep Asst Sec for Tech Policy, Dept of Commerce |
Tobias Rodill | n/a |
Ian Musselman | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Medicare
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Amendment
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Federal Trade Commission (FTC)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Federal Trade Commission (FTC)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Federal Trade Commission (FTC)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Federal Trade Commission (FTC)
Type of Issue
Registration
Issue(s) they said they’d lobby about: Medicare Issues; Drug Importation; International Trade; FDA Issues; Patent Reform.
Registration
Issue(s) they said they’d lobby about: Medicare Issues; Drug Importation; International Trade; FDA Issues; Patent Reform.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate